Rankings
▼
Calendar
RNA FY 2018 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RNA
Avidity Biosciences, Inc.
$2B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$379,000
Gross Profit
-$8M
-2125.9% margin
Operating Income
-$10M
-2769.9% margin
Net Income
-$12M
-3148.8% margin
EPS (Diluted)
$-0.58
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$60,000
Balance Sheet
Total Assets
$4M
Total Liabilities
$45M
Stockholders' Equity
-$41M
Cash & Equivalents
$3M
← Q1 2019
All Quarters